Holen Sie sich die Stockscreener-App
1.54
0.00%
0.00
Handel nachbörslich:
1.54
Schlusskurs vom Vortag:
$1.54
Offen:
$1.52
24-Stunden-Volumen:
294.90K
Relative Volume:
0.87
Marktkapitalisierung:
$222.97M
Einnahmen:
$18.67M
Nettoeinkommen (Verlust:
$-64.78M
KGV:
-2.6694
EPS:
-0.5769
Netto-Cashflow:
$-37.02M
1W Leistung:
-1.28%
1M Leistung:
-18.52%
6M Leistung:
-8.33%
1J Leistung:
-26.32%
1-Tages-Spanne:
$1.52
$1.5641
1-Wochen-Bereich:
$1.52
$1.61
52-Wochen-Spanne:
$1.22
$2.295
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.54 | 222.97M | 18.67M | -64.78M | -37.02M | -0.5769 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
| 2023-04-13 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-22 | Eingeleitet | Cowen | Outperform |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-20 | Eingeleitet | Truist | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
| 2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
OABI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Leerink reiterates Outperform on OmniAb stock after partner trial fails - Investing.com UK
Leerink reiterates Outperform on OmniAb stock, $10 target - Investing.com UK
Leerink reiterates Outperform on OmniAb stock after partner trial fails By Investing.com - au.investing.com
Retail Trends: Should you avoid OmniAb Inc Equity Warrant stock right now2026 Geopolitical Influence & Proven Capital Preservation Tips - baoquankhu1.vn
Insider Buy: Whats the beta of OmniAb Inc Equity Warrant stockEarnings Performance Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and OmniAb (OABI) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Here Is Why You Should Not Ignore OmniAb Inc. (OABI) - insidermonkey.com
OmniAb (NASDAQ:OABI) Trading 3.3% HigherWhat's Next? - MarketBeat
Earnings Miss: What drives OmniAb Inc Equity Warrants stock price2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
Truist reiterates OmniAb stock Buy rating on biotech recovery By Investing.com - Investing.com Australia
Truist reiterates OmniAb stock Buy rating on biotech recovery - Investing.com
Shorts Report: What analysts say about OmniAb Inc stock2026 Macro Moves & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Nasdaq Moves: Will OmniAb Inc stock go up in YEAREarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
Jobs Data: How correlated is OmniAb Inc to the S P5002026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Market Outlook: What drives OmniAb Inc Equity Warrants stock priceWeekly Loss Report & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Quarterly Risk: Is OmniAb Inc Equity Warrant a stock for growth or value investors2026 Update & Capital Protection Trade Alerts - baoquankhu1.vn
Quarterly Risk: Can OmniAb Inc disrupt its industryTrade Risk Report & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aug Wrap: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2026 Rallies & Precise Buy Zone Identification - baoquankhu1.vn
WOODSTOCK CORP's OmniAb Inc(OABI) Holding History - GuruFocus
If You Invested $1,000 in OmniAb, Inc. (OABI) - Stock Titan
Buyback Watch: What dividend growth rate does OmniAb Inc offer2026 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
OmniAb files to sell 21.25M shares of common stock for holders - MSN
History Review: What is OmniAb Incs market position2026 Market Mood & High Accuracy Trade Alerts - baoquankhu1.vn
Take Profit: Can TLRY stock double in the next yearMarket Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Update Recap: Is OmniAb Inc stock undervalued right nowOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Aug Selloffs: Is OmniAb Inc Equity Warrant a stock for growth or value investorsWeekly Trend Summary & Stepwise Swing Trade Plans - baoquankhu1.vn
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year - AOL.com
Novanta Stock Has Underperformed This Past Year, but One Investor Just Made a $36 Million Bet on Shares - AOL.com
Tuniu (TOUR) Q4 2025 Earnings Call Transcript - AOL.com
OmniAb 2025 Growth: 107 Partners, 407 Programs, and New OmniUltra LaunchNews and Statistics - IndexBox
OmniAb (OABI) Q4 2025 Earnings Call Transcript - The Globe and Mail
Is OmniAb Inc benefiting from innovation trends2026 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn
Earnings call transcript: OmniAb beats Q4 2025 EPS forecast, stock rises - Investing.com Nigeria
Urban One (UONE) Q4 2025 Earnings Call Transcript - AOL.com
Earnings Miss: Will OmniAb Inc Equity Warrant benefit from rising consumer demandEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
OmniAb outlines $25M–$30M 2026 revenue guidance as partner pipeline accelerates with OmniUltra and xPloration launches - MSN
OmniAb Earnings Call Highlights Platform Growth, Cash Path - The Globe and Mail
Ideal Power (IPWR) Q4 2025 Earnings Transcript - AOL.com
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Cresco Labs (OtherCRLBF) - The Globe and Mail
OmniAb : March 2026 Corporate Overview - marketscreener.com
Q1 Earnings Forecast for OmniAb Issued By HC Wainwright - MarketBeat
OmniAb, Inc. (OABI) reports Q4 loss, misses revenue estimates - MSN
OmniAb (NASDAQ:OABI) Upgraded to Hold at Wall Street Zen - MarketBeat
Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI) - The Globe and Mail
Benchmark Maintains Buy on OmniAb, Inc. (OABI) March 2026 - Meyka
US Market Wrap: Is OmniAb Inc stock undervalued right now2025 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Revenue Check: Does OmniAb Inc stock have upside surprise potential - baoquankhu1.vn
Benchmark reiterates Buy on OmniAb stock, keeps $4 target By Investing.com - za.investing.com
Benchmark reiterates Buy on OmniAb stock, keeps $4 target - Investing.com
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omniab Inc-Aktie (OABI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Berkman Charles S | Chief Legal Officer |
Feb 18 '26 |
Sale |
1.71 |
9,673 |
16,541 |
392,700 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Feb 18 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
278,152 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Feb 18 '26 |
Sale |
1.71 |
9,301 |
15,905 |
268,851 |
| FOEHR MATTHEW W | President and CEO |
Feb 18 '26 |
Sale |
1.71 |
30,843 |
52,742 |
4,403,277 |
| FOEHR MATTHEW W | President and CEO |
Feb 16 '26 |
Option Exercise |
0.00 |
36,458 |
0 |
4,396,541 |
| FOEHR MATTHEW W | President and CEO |
Feb 17 '26 |
Sale |
1.70 |
20,754 |
35,282 |
4,375,787 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Feb 16 '26 |
Option Exercise |
0.00 |
13,542 |
0 |
266,230 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Feb 17 '26 |
Sale |
1.70 |
6,828 |
11,608 |
259,402 |
| Berkman Charles S | Chief Legal Officer |
Feb 16 '26 |
Option Exercise |
0.00 |
13,542 |
0 |
390,613 |
| Berkman Charles S | Chief Legal Officer |
Feb 17 '26 |
Sale |
1.70 |
6,990 |
11,883 |
383,623 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):